Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Aridis Pharmaceuticals, Inc. (ARDS) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $2.12 Metrics
OS: 36.1 M
Market cap: $76.5 M
Net cash: $1.32 M $0.04 per share
EV: $75.2 M

 
TTM Valuation
EBITDA ($30.6) M
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
Revenues1.51.01.02.80.92.1
            Revenue growth53.5%-2.2%-62.9%220.6%-58.4% 
Cost of goods sold0.00.00.00.00.00.0
Gross profit1.51.01.02.80.92.1
            Gross margin100.0%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative     0.0
Research and development36.917.024.123.017.4 
General and administrative7.36.46.03.93.20.0
EBITA-42.7-22.4-30.0-24.1-19.7-7.9
            EBITA margin-2782.5%-2241.0%-2938.6%-873.1%-2294.5%-381.2%
Amortization of intangibles  0.00.00.0 
EBIT-42.7-22.4-30.0-24.1-19.7-7.9
            EBIT margin-2782.5%-2241.0%-2939.1%-873.3%-2295.1%-381.2%
Pre-tax income-42.2-22.3-29.7-22.1-24.7-8.4
Income taxes0.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income-46.3-22.3-29.7-23.5-27.4-8.9
            Net margin-3017.6%-2233.3%-2904.2%-851.0%-3191.7%-429.7%
 
Diluted EPS($3.77)($2.44)($3.51)($7.46)$185,215.92$3,173.93
Shares outstanding (diluted)12.39.28.53.10.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy